Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Gryrotonic Training in Behcet-diseased Elders With Breast Cancer

5. november 2026 opdateret af: Ali Mohamed Ali ismail, Cairo University

gryrotonic training may be a good exercise modality in Behcet-diseased elders with breast cancer

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

forty Behcet-diseased elders with breast cancer will randomy divide into group I (receive gyrotonic exercise three session weekly for 12 week) or group II (wait list)

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

40

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

  • Egypten
    • Dokki
      • Giza, Dokki, Egypten
        • Rekruttering
        • Cairo University
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

65 år til 75 år (Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion Criteria:

  • beast cancer survivors
  • behcet diseas patients

Exclusion Criteria:

  • cardiac or repiratory or renal failure patients

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: group number 1

twenty Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will 45 min
Adfærdsmæssigt: exercise

twnety Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will last for 45 min
Ingen indgriben: group number 2

twenty Behcet-diseased elders who survivied from breast cancer will be wait list for 12 weeks

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Short Physical Performance Battery
Tidsramme: it will be measured after 12 weeks

the total score will be calcualted
it will be measured after 12 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Dual task gait speed
Tidsramme: It will be measured after 12 weeks

this task assess gait speed
It will be measured after 12 weeks
Four-square step test
Tidsramme: It will be measured after 12 weeks

it is fucntional balnce test
It will be measured after 12 weeks
grip strenghts
Tidsramme: It will be measured after 12 weeks

it is a measure of grip strenghths in dominant hand
It will be measured after 12 weeks
time up- and go testing
Tidsramme: It will be measured after 12 weeks

it is a measure of fall risk
It will be measured after 12 weeks
sit-to-stand 30-second testing
Tidsramme: It will be measured after 12 weeks

asess number of repteations of sit-to-staning in 30 seconds
It will be measured after 12 weeks
six minute walking testingg
Tidsramme: It will be measured after 12 weeks

distance covered by subject in six minutes wil be assessed
It will be measured after 12 weeks
10-meters walking testing
Tidsramme: It will be measured after 12 weeks

time covered for walking for ten meter will be assessed
It will be measured after 12 weeks
trunk-flexor McGill core endurance test
Tidsramme: It will be measured after 12 weeks

this test will assess endurance of trunk flexors
It will be measured after 12 weeks
trunk-extensor McGill core endurance test
Tidsramme: It will be measured after 12 weeks

this test will assess endurance of trunk extensors
It will be measured after 12 weeks
right-lateral-trunk-bending McGill core endurance test
Tidsramme: It will be measured after 12 weeks

this test will assess endurance of right lateral trunk bendors
It will be measured after 12 weeks
left-lateral-trunk-bending McGill core endurance test
Tidsramme: It will be measured after 12 weeks

this test will assess endurance of left lateral trunk bendors
It will be measured after 12 weeks
arm flexion in thrity seconds
Tidsramme: It will be measured after 12 weeks

it will assess numbers (repeations) of arm flexion in thirty second
It will be measured after 12 weeks
maximal nubmer of push up
Tidsramme: It will be measured after 12 weeks

this will assess maximal number of performed psh ups in speciifc time
It will be measured after 12 weeks
behcet disease quality of life
Tidsramme: It will be measured after 12 weeks

questioanire that will assess life quality in behcet disease (total score will be estiamted)
It will be measured after 12 weeks
total score of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess quality of life
It will be measured after 12 weeks
physical fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess physical fucntion related quality of life
It will be measured after 12 weeks
role fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess role fucntion related quality of life
It will be measured after 12 weeks
emotional fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess emotional fucntion related quality of life
It will be measured after 12 weeks
cognitive fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess cognitive fucntion related quality of life
It will be measured after 12 weeks
social fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess social fucntion related quality of life
It will be measured after 12 weeks
fatigue fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess fatigue
It will be measured after 12 weeks
nausea-vomiting subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess nausea-vomiting
It will be measured after 12 weeks
pain subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess pain
It will be measured after 12 weeks
dyspnea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess dyspnea
It will be measured after 12 weeks
insomnia subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess insomnia
It will be measured after 12 weeks
appetite-loss subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess appetite loss
It will be measured after 12 weeks
constipation subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess constipation
It will be measured after 12 weeks
diarrhea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess diarrhea
It will be measured after 12 weeks
financial difficulties subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess financial difficulties
It will be measured after 12 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Cairo University

Efterforskere

  • Ledende efterforsker: Ali MA Ismail, phd, Cairo University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

30. november 2026

Primær færdiggørelse (Anslået)

30. maj 2027

Studieafslutning (Anslået)

30. maj 2027

Datoer for studieregistrering

Først indsendt

5. november 2026

Først indsendt, der opfyldte QC-kriterier

5. november 2026

Først opslået (Faktiske)

10. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

10. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

5. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • IRB00014233-118

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner